CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 837 of 865
Non-Antibody Products
Page 837 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Valproic Acid Acyl-D-Glucuronide | A metabolite of valproic acid | 500 µg | 22459-500 | More Info |
| Valproic Acid-d4 | An internal standard for the quantification of valproic acid by GC- or LC-… | 1 mg | 39966-1 | More Info |
| Valproic Acid-d4 | An internal standard for the quantification of valproic acid by GC- or LC-… | 10 mg | 39966-10 | More Info |
| Valproic Acid-d4 | An internal standard for the quantification of valproic acid by GC- or LC-… | 25 mg | 39966-25 | More Info |
| Valproic Acid-d4 | An internal standard for the quantification of valproic acid by GC- or LC-… | 5 mg | 39966-5 | More Info |
| Valproic Acid-d4 (sodium salt) | An internal standard for the quantification of valproic acid by GC- or LC-… | 1 mg | 22090-1 | More Info |
| Valproic Acid-d4 (sodium salt) | An internal standard for the quantification of valproic acid by GC- or LC-… | 5 mg | 22090-5 | More Info |
| Valproic Acid-d4 (sodium salt) | An internal standard for the quantification of valproic acid by GC- or LC-… | 500 µg | 22090-500 | More Info |
| Valproic Acid (sodium salt) | An analog of valeric acid; inhibits class I HDACs (IC50s = ~2 mM); the num… | 10 g | 13033-10 | More Info |
| Valproic Acid (sodium salt) | An analog of valeric acid; inhibits class I HDACs (IC50s = ~2 mM); the num… | 100 g | 13033-100 | More Info |
| Valproic Acid (sodium salt) | An analog of valeric acid; inhibits class I HDACs (IC50s = ~2 mM); the num… | 25 g | 13033-25 | More Info |
| Valproic Acid (sodium salt) | An analog of valeric acid; inhibits class I HDACs (IC50s = ~2 mM); the num… | 50 g | 13033-50 | More Info |
| Valrocemide | An anticonvulsant; protects against MES-, PTZ-, picrotoxin-, or bicucullin… | 100 mg | 30909-100 | More Info |
| Valrocemide | An anticonvulsant; protects against MES-, PTZ-, picrotoxin-, or bicucullin… | 250 mg | 30909-250 | More Info |
| Valrocemide | An anticonvulsant; protects against MES-, PTZ-, picrotoxin-, or bicucullin… | 50 mg | 30909-50 | More Info |
| Valrubicin | A semisynthetic anthracycline antitumor antibiotic; inhibits the growth of… | 1 mg | 22964-1 | More Info |
| Valrubicin | A semisynthetic anthracycline antitumor antibiotic; inhibits the growth of… | 5 mg | 22964-5 | More Info |
| Valrubicin | A semisynthetic anthracycline antitumor antibiotic; inhibits the growth of… | 500 µg | 22964-500 | More Info |
| Valsartan | An AT1 receptor antagonist (IC50 = 2.7 nM); 20,000-fold selective for AT1… | 10 mg | 14178-10 | More Info |
| Valsartan | An AT1 receptor antagonist (IC50 = 2.7 nM); 20,000-fold selective for AT1… | 100 mg | 14178-100 | More Info |
| Valsartan | An AT1 receptor antagonist (IC50 = 2.7 nM); 20,000-fold selective for AT1… | 25 mg | 14178-25 | More Info |
| Valsartan | An AT1 receptor antagonist (IC50 = 2.7 nM); 20,000-fold selective for AT1… | 50 mg | 14178-50 | More Info |
| Valsartan Acid | A valsartan transformation product; formed during activated sludge treatme… | 1 mg | 35361-1 | More Info |
| Valsartan Acid | A valsartan transformation product; formed during activated sludge treatme… | 5 mg | 35361-5 | More Info |
| Valsartan-d9 | An internal standard for the quantification of valsartan by GC- or LC-MS | 1 mg | 25226-1 | More Info |
| Valtrate | A valepotriate with diverse biological activities; inhibits nuclear export… | 1 mg | 36522-1 | More Info |
| Valtrate | A valepotriate with diverse biological activities; inhibits nuclear export… | 10 mg | 36522-10 | More Info |
| Valtrate | A valepotriate with diverse biological activities; inhibits nuclear export… | 25 mg | 36522-25 | More Info |
| Valtrate | A valepotriate with diverse biological activities; inhibits nuclear export… | 5 mg | 36522-5 | More Info |
| Vancomycin (hydrochloride) | A glycopeptide antibiotic identified for its utility in the treatment of g… | 1 g | 15327-1 | More Info |
| Vancomycin (hydrochloride) | A glycopeptide antibiotic identified for its utility in the treatment of g… | 250 mg | 15327-250 | More Info |
| Vancomycin (hydrochloride) | A glycopeptide antibiotic identified for its utility in the treatment of g… | 5 g | 15327-5 | More Info |
| Vandetanib | A multi-kinase inhibitor that inhibits VEGFR2, VEGFR3, VEGFR1, EGFR, PDGFR… | 10 mg | 14706-10 | More Info |
| Vandetanib | A multi-kinase inhibitor that inhibits VEGFR2, VEGFR3, VEGFR1, EGFR, PDGFR… | 100 mg | 14706-100 | More Info |
| Vandetanib | A multi-kinase inhibitor that inhibits VEGFR2, VEGFR3, VEGFR1, EGFR, PDGFR… | 25 mg | 14706-25 | More Info |
| Vandetanib | A multi-kinase inhibitor that inhibits VEGFR2, VEGFR3, VEGFR1, EGFR, PDGFR… | 5 mg | 14706-5 | More Info |
| Vandetanib-d6 | An internal standard for the quantification of vandetanib by GC- or LC-MS | 1 mg | 28710-1 | More Info |
| Vandetanib-d6 | An internal standard for the quantification of vandetanib by GC- or LC-MS | 5 mg | 28710-5 | More Info |
| Vandetanib-d6 | An internal standard for the quantification of vandetanib by GC- or LC-MS | 500 µg | 28710-500 | More Info |
| Vanillic Acid | A phenol with diverse biological activities; inhibits biofilm formation by… | 100 g | 39643-100 | More Info |
| Vanillic Acid | A phenol with diverse biological activities; inhibits biofilm formation by… | 25 g | 39643-25 | More Info |
| Vanillic Acid | A phenol with diverse biological activities; inhibits biofilm formation by… | 250 g | 39643-250 | More Info |
| Vanillic Acid | A phenol with diverse biological activities; inhibits biofilm formation by… | 50 g | 39643-50 | More Info |
| Vanillic Acid 4-β-D-glucopyranoside | A hydrolyzable tannin that can be phytotoxic against different species | 1 mg | 19759-1 | More Info |
| Vanillic Acid 4-β-D-glucopyranoside | A hydrolyzable tannin that can be phytotoxic against different species | 10 mg | 19759-10 | More Info |
| Vanillic Acid 4-β-D-glucopyranoside | A hydrolyzable tannin that can be phytotoxic against different species | 5 mg | 19759-5 | More Info |
| Vanillin | An analytical reference standard categorized as a precursor in the synthes… | 100 mg | 36422-100 | More Info |
| Vanillin | An analytical reference standard categorized as a precursor in the synthes… | 25 mg | 36422-25 | More Info |
| Vanillin 4-O-β-D-Glucoside | A vanillin precursor; the storage form of vanillin | 10 mg | 35908-10 | More Info |
| Vanillin 4-O-β-D-Glucoside | A vanillin precursor; the storage form of vanillin | 25 mg | 35908-25 | More Info |
| Vanillin 4-O-β-D-Glucoside | A vanillin precursor; the storage form of vanillin | 5 mg | 35908-5 | More Info |
| Vanoxonin | A bacterial metabolite; inhibits thymidylate synthetase (IC50 = 0.7 µ… | 1 mg | 32931-1 | More Info |
| Vapendavir | A capsid-binding antiviral agent; inhibits the cytopathic effects of HRV2… | 1 mg | 30546-1 | More Info |
| Vapendavir | A capsid-binding antiviral agent; inhibits the cytopathic effects of HRV2… | 10 mg | 30546-10 | More Info |
| Vapendavir | A capsid-binding antiviral agent; inhibits the cytopathic effects of HRV2… | 25 mg | 30546-25 | More Info |
| Vapendavir | A capsid-binding antiviral agent; inhibits the cytopathic effects of HRV2… | 5 mg | 30546-5 | More Info |
| Vapendavir-d5 | An internal standard for the quantification of vapendavir by GC- or LC-MS | 1 mg | 31320-1 | More Info |
| Vapendavir-d5 | An internal standard for the quantification of vapendavir by GC- or LC-MS | 5 mg | 31320-5 | More Info |
| Vapendavir-d5 | An internal standard for the quantification of vapendavir by GC- or LC-MS | 500 µg | 31320-500 | More Info |
| Vapreotide (trifluoroacetate salt) | A peptide NK1 receptor antagonist (IC50 = 330 nM in a radioligand binding… | 1 mg | 24558-1 | More Info |
| Vapreotide (trifluoroacetate salt) | A peptide NK1 receptor antagonist (IC50 = 330 nM in a radioligand binding… | 500 µg | 24558-500 | More Info |
| Vardenafil-d5 | An internal standard for the quantification of vardenafil by GC- or LC-MS | 1 mg | 25225-1 | More Info |
| Vardenafil-d5 | An internal standard for the quantification of vardenafil by GC- or LC-MS | 500 µg | 25225-500 | More Info |
| Vardenafil (hydrochloride hydrate) | An inhibitor of PDE5 (IC50s = 0.2-1.2 nM) and PDE6 (IC50 = 2 nM); selectiv… | 10 mg | 14930-10 | More Info |
| Vardenafil (hydrochloride hydrate) | An inhibitor of PDE5 (IC50s = 0.2-1.2 nM) and PDE6 (IC50 = 2 nM); selectiv… | 100 mg | 14930-100 | More Info |
| Vardenafil (hydrochloride hydrate) | An inhibitor of PDE5 (IC50s = 0.2-1.2 nM) and PDE6 (IC50 = 2 nM); selectiv… | 25 mg | 14930-25 | More Info |
| Vardenafil (hydrochloride hydrate) | An inhibitor of PDE5 (IC50s = 0.2-1.2 nM) and PDE6 (IC50 = 2 nM); selectiv… | 50 mg | 14930-50 | More Info |
| Varenicline-d4 | An internal standard for the quantification of varenicline by GC- or LC-MS | 1 mg | 26102-1 | More Info |
| Varenicline-d4 | An internal standard for the quantification of varenicline by GC- or LC-MS | 500 µg | 26102-500 | More Info |
| Varenicline (tartrate) | An agonist of α7 and α4β2 nAChRs (EC50s = 18 and 2.3 &mic… | 10 mg | 15030-10 | More Info |
| Varenicline (tartrate) | An agonist of α7 and α4β2 nAChRs (EC50s = 18 and 2.3 &mic… | 25 mg | 15030-25 | More Info |
| Varenicline (tartrate) | An agonist of α7 and α4β2 nAChRs (EC50s = 18 and 2.3 &mic… | 5 mg | 15030-5 | More Info |
| Varenicline (tartrate) | An agonist of α7 and α4β2 nAChRs (EC50s = 18 and 2.3 &mic… | 50 mg | 15030-50 | More Info |
| Variculanol | A sesquiterpene | 1 mg | 29064-1 | More Info |
| Varinolic Acid | An analytical reference standard categorized as an intermediate in the phy… | 1 mg | 26283-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile